Objective: Central type primitive neuroectodermal tumors (PNET) are some of the most frequent somatic type tumors derived from germ cell tumors and can metastasize. We studied the cytomorphological features of metastatic central type PNET by fine-needle aspiration (FNA). Materials and Methods: A computerized search of our laboratory information system was performed for the 9-year period from 2005 through 2014 to identify all cytology cases in which a diagnosis of metastatic central type PNET had been rendered. A total of 5 FNA cases were collected and direct smears were reexamined. Results: All patients had a history of testicular or ovarian germ cell tumors. Direct smears displayed single and clusters of atypical round to oval cells with scant to moderate cytoplasm. Abundant naked nuclei were present in Diff-Quik-stained smears with mild to marked crushed artifacts and nuclear molding. Tumor cells showed fine granular chromatin, nuclear size variation (up to 1:3), and one or more small nucleoli. Pseudorosettes (Homer Wright-like rosette) were noticed in 1 case. Tumor cells were commonly positive for synaptophysin. Conclusion: Metastatic PNET can be reliably diagnosed by FNA. Differential diagnoses include Ewing sarcoma/peripheral PNET, alveolar rhabdomyosarcoma, neuroblastoma, etc. It is important to be familiar with this entity to avoid diagnostic pitfalls.

Keywords:
Central type primitive neuroectodermal tumor, Germ cell tumor, Fine-needle aspiration
1.
Kleinman GM, Young RH, Scully RE: Primary neuroectodermal tumors of the ovary: a report of 25 cases. Am J Surg Pathol 1993;17:764-778.
2.
Michael H, Hull MT, Ulbright TM, Foster RS, Miller KD: Primitive neuroectodermal tumors arising in testicular germ cell neoplasms. Am J Surg Pathol 1997;21:896-904.
3.
Ulbright TM, Hattab EM, Zhang S, Ehrlich Y, Foster RS, Einhorn LH, Cheng L: Primitive neuroectodermal tumors in patients with testicular germ cell tumors usually resemble pediatric-type central nervous system embryonal neoplasms and lack chromosome 22 rearrangements. Mod Pathol 2010;23:972-980.
4.
Burger P, Scheithauer B: Diagnostic Pathology: Neuropathology, ed 1. Manitoba, Lippincott Williams & Wilkins, 2012.
5.
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW: The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131:803-820.
6.
Gibas Z, Prout GR, Pontes JE, Sandberg AA: Chromosome changes in germ cell tumors of the testis. Cancer Genet Cytogenet 1986;19:245-252.
7.
Ehrlich Y, Beck SD, Ulbright TM, Cheng L, Brames MJ, Andreoiu M, Foster RS, Einhorn LH: Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor. Ann Oncol 2010;21:1846-1850.
8.
Al-Hader AA, Jain A, Al-Nasrallah N, Einhorn LH: Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy. Am J Clin Oncol 2015;38:364-366.
9.
Lai X, Chen S: Identification of novel biomarker candidates for immunohistochemical diagnosis to distinguish low-grade chondrosarcoma from enchondroma. Proteomics 2015;15:2358-2368.
10.
Klijanienko J, Couturier J, Bourdeaut F, Freneaux P, Ballet S, Brisse H, Lagace R, Delattre O, Pierron G, Vielh P, Sastre-Garau X, Michon J: Fine-needle aspiration as a diagnostic technique in 50 cases of primary Ewing sarcoma/peripheral neuroectodermal tumor: Institut Curie's experience. Diagn Cytopathol 2012;40:19-25.
11.
Trujillo AJ, Gopez EV, Collins BT: Endoscopic ultrasound-guided fine-needle aspiration of metastatic alveolar rhabdomyosarcoma to the pancreas with fluorescence in situ hybridization: a case report. Diagn Cytopathol 2011;39:612-615.
12.
Silverman JF, Dabbs DJ, Ganick DJ, Holbrook CT, Geisinger KR: Fine needle aspiration cytology of neuroblastoma, including peripheral neuroectodermal tumor, with immunocytochemical and ultrastructural confirmation. Acta Cytol 1988;32:367-376.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.